Atlas Trials

Study of N-acetylcysteine in the Treatment of Patients With the m.3243A>G Mutation and Low Brain Glutathione Levels

Clinical trial NCT05241262 · RECRUITING

Trial details

NCT number
NCT05241262
Sponsor
Michio Hirano, MD
Status
RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Mitochondrial Disease
Start date
2023-07-06
Primary completion
2026-03-01
Enrollment
18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.